A new research project aims to make it easier for people with acute myeloid leukemia (AML) to participate in clinical…
Articles by Marisa Wexler, MS
An experimental cancer therapy known as atebimetinib is delivering “extraordinary” results for patients with pancreatic cancer. New data from…
The European Commission has approved Voranigo (vorasidenib) for certain types of glioma, marking the arrival of a new…
The U.S. Food and Drug Administration (FDA) has agreed to review Corcept Therapeutics’ application seeking approval of relacorilant to…
Combination treatment with Tecvayli (teclistamab-cqyv) and Darzalex Faspro (daratumumab and hyaluronidase-fihj) led to a 100% response rate for…
The National Comprehensive Cancer Network (NCCN), a nonprofit alliance of 33 cancer centers, included Revuforj (revumenib) in its clinical practice…
Over a 15-year period, the median survival time for people with myeloma has nearly doubled, increasing from 2.4 years…
The advocacy organization Blood Cancer United has teamed up with motor oil company Valvoline Global and auto racing group…
The U.S. Food and Drug Administration (FDA) has approved two new biosimilar drugs — versions of brand-name therapies that have…
The U.S. Food and Drug Administration (FDA) has granted fast track designation to CER-1236, an experimental cell therapy that…